Shuai Chen

Dr. Shuai Chen


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
HZHong-Ju Zhang
Hong-Ju Zhang
SWSheng-Hui Wang
Sheng-Hui Wang
YBYing-Ying Bai
Ying-Ying Bai
JZJie-Wen Zhang
Jie-Wen Zhang
SCShuai Chen
Shuai Chen
Introduction: The structural and functional damages of the striatum were evident in idiopathic REM sleep behavior disorder (iRBD). With the research on iRBD deepens, cognitive impairment in iRBD is getting increasing attention. However, the mechanism of cognitive impairment in iRBD was poorly understood.Methods: Neuropsychological assessment was carried out in 21 polysomnographies (PSGs) confirmed iRBD patients and 22 normal controls. Both regional homogeneity (ReHo) and seed-based functional connectivity (FC) rs-fMRI analyses were applied to explore the FC abnormalities and its association with cognition in iRBD patients. Positive ReHo clusters were set as seeds for further FC analysis.Results: Idiopathic REM sleep behavior disorder patients presented cognitive deficits in attention/working memory, executive function, immediate memory, and visuo-spatial ability. ReHo analysis revealed abnormal spontaneous brain activities in the striatum (right caudate, left pallidum and bilateral putamen) in iRBD. FC analysis showed decreased striatum-related FCs in the frontal, temporal, occipital lobes, thalamus, anterior cingulate gyrus, as well as decreased intrinsic FCs between bilateral putamen and between caudate and pallidum. Deficits in attention/working memory, executive function, and immediate memory were associated with abnormal striatal-cortical FCs including frontal, temporal, and anterior cingulate cortices.Conclusion: Functional changes of striatum and cognitive impairment in iRBD were reconfirmed in the present study. Abnormal striatal-cortical networks, especially the striatal-frontal network, contribute to the working memory/executive function deficits in iRBDs. These findings supported the role of striatum not only in motor but also in cognition impairment in iRBD.

3 November 2021 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
SCShuai Chen
Shuai Chen
JZJin‐Long Zou
Jin‐Long Zou
SHShuang He
Shuang He
WLWei Li
Wei Li
JZJie-Wen Zhang
Jie-Wen Zhang
SLShu-Jian Li
Shu-Jian Li
Objective: Hereditary spastic paraplegia (HSP) due to ERLIN2 gene mutations was designated as spastic paraplegia 18 (SPG18). To date, SPG18 families/cases are still rarely reported. All early reported cases shared the autosomal recessive (AR) inheritance pattern. Over the past 3 years, autosomal dominant (AD) or sporadic SPG18 cases had been continuously reported. Here, we reported the clinical and genetic features of the first autosomal dominant SPG18 pedigree in Chinese.Methods: We conducted detailed medical history inquiry, neurological examinations of the proband and his family members, and charted the family tree. The proband underwent brain and cervical magnetic resonance imaging (MRI), electromyography (EMG), and whole exome sequencing. Sanger sequencing was performed to verify the genetic variation in the proband and some family members. A literature review of all reported SPG18 families/cases was carried out to summarize the clinical‐genetic characteristics of SPG18 under different inheritance patterns.Results: Four patients were clinically diagnosed as chronic spastic paraplegia in three consecutive generations with the autosomal dominant inheritance model. All the patients presented juvenile‐adolescent onset and gradually worsening pure HSP phenotype. Clinical phenotypes were consistent within the family. Whole exome sequencing in the proband identified a previously reported heterozygous c.502G > A (p.V168M) mutation in exon 8 of ERLIN2 gene. This mutation was cosegregated with the phenotype in the family and was classified as likely pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines. To date, eight AR‐SPG18 families, five AD‐SPG18 families, and three sporadic cases had been reported. Clinical phenotype of AD‐SPG18 was juvenile‐adolescent onset pure HSP, while the phenotype of AR‐SPG18 was mostly complicated HSP with earlier onset and more severe conditions. In rare cases, the initial spastic paraplegia could evolve to rapidly progressive amyotrophic lateral sclerosis (ALS).Conclusions: We reported the first autosomal dominant SPG18 pedigree in Chinese Han population, which added more pathogenic evidence for V168M mutation. As more SPG18 cases reported, the essentials of SPG18 need to be updated in clinical practice. Special attentions should be given in gene test for upper motor neuron disorders in case of missing heterozygous mutations in ERLIN2.

8 January 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
MWMeng-Yun Wang
Meng-Yun Wang
RXRan Xin
Ran Xin
JSJing-Yu Shao
Jing-Yu Shao
SWSheng-Hui Wang
Sheng-Hui Wang
HYHong-Qi Yang
Hong-Qi Yang
SCShuai Chen
Shuai Chen

15 October 2024 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JSJing-Yu Shao
Jing-Yu Shao
MWMeng-Yun Wang
Meng-Yun Wang
RLRong Li
Rong Li
HYHong-Qi Yang
Hong-Qi Yang
XHXin-Xin He
Xin-Xin He
SCShuai Chen
Shuai Chen

31 March 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
SHShuang He
Shuang He
SCShuai Chen
Shuai Chen
SLShu‐Jian Li
Shu‐Jian Li
JZJie-Wen Zhang
Jie-Wen Zhang
XLXin-Liang Liang
Xin-Liang Liang
Objective: Roberts syndrome (RBS), also known as Roberts‐SC phocomelia syndrome, is a rare autosomal recessive developmental disorder caused by mutations in the ESCO2 gene. Cardinal clinical manifestations are pre‐ and postnatal growth retardation and craniofacial and limb malformations. Here, we report RBS in a Chinese adolescent with novel biallelic ESCO2 variations and complex cerebrovascular diseases.Methods: Medical history, neurological examinations, neuroimaging, and pathology were collected in the proband and the family. Whole exome sequencing (WES) with copy number variation analysis was performed to screen for genetic variations.Results: The clinical features of the proband were craniofacial and limb malformations together with complex cerebrovascular diseases. She suffered ischemic stroke at 6 years old and died of cerebellar hemorrhage secondary to an aneurysm at 13 years old. Besides, neuroimaging showed the triad of leukoencephalopathy, calcifications, and cysts. Brain histopathology revealed angiomatous changes and perivascular cysts suggesting chronic small cerebral vasculopathy. Whole exome sequencing (WES) identified novel biallelic variations in the ESCO2 gene (c.1220A>T, p.H407L and c.1562delC, p.A521fs).Conclusions: We describe complex cerebrovascular diseases in Roberts syndrome caused by novel ESCO2 biallelic variations. This case expands not only the cerebral involvement in Roberts syndrome but also the disease spectrum of the neuroimaging triad with leukoencephalopathy, calcifications, and cysts.

27 October 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
JSJing-Yu Shao
Jing-Yu Shao
YSYu Shen
Yu Shen
RLRong Li
Rong Li
XXXue-Feng Xiang
Xue-Feng Xiang
CLChen-Hong Li
Chen-Hong Li
JZJiewen Zhang
Jiewen Zhang
Background: In Parkinson's disease (PD), striatal dopaminergic degeneration follows a posterior-anterior gradient, with asymmetric involvement and an exponential decline in early disease stages. Previous investigations of the relationship between striatal dopamine transporter (DAT) availability and cognitive impairment in PD have been insufficient, especially in longitudinal studies. Objective: To examine the longitudinal associations between baseline DAT availability and cognitive milestone (CogM) from the perspectives of striatal subregions, laterality, and nonlinear threshold effects. Methods: A total of 467 patients with early, sporadic PD without CogM and with available striatal DAT data at baseline were included from the Parkinson's Progression Markers Initiative database. Annual follow-up data over eight years were analyzed. Standard multivariable Cox and restricted cubic spline (RCS) Cox models were used to assess the associations between DAT uptake and CogM. Two-piecewise Cox regression was used to explore potential threshold effects. Results: The 8-year cumulative probability of being CogM-free was 66.0%. In multivariable Cox models, DAT uptake in the ipsilateral, but not contralateral, caudate and putamen was inversely associated with CogM. RCS Cox models revealed a linear negative association for the ipsilateral caudate, but an L-shaped association for the ipsilateral putamen. Two-piecewise Cox regression identified a threshold effect at a DAT uptake of 1.04 in the ipsilateral putamen, below which the risk of CogM increased significantly. Conclusions: Baseline ipsilateral caudate DAT uptake shows a linear inverse relationship with CogM, highlighting its potential as an early predictive biomarker. The L-shaped association observed for ipsilateral putamen DAT warrants further mechanistic investigation.